Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Nick Pizzie

CFO at Axsome Therapeutics, Inc. (AXSM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.2M

Reported trades

Filed Stock Type Shares Price Value Since
Jun 9SEC AXSMAxsome Therapeutics, Inc. Sell Plan 33,00042,867 held (−43%) $240.09 $7.9M -34.5%
Jan 23SEC AXSMAxsome Therapeutics, Inc. Sell Plan 12,00042,588 held (−22%) $187.92 $2.3M -16.4%
  • Sell

    CFO Nick Pizzie sold $7.9M of AXSM at $240.09 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Nick Pizzie sold $2.3M of AXSM at $187.92 — pre-scheduled 10b5-1 plan sale.